182 related articles for article (PubMed ID: 25605402)
1. Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Lorenz F; Marklund S; Werner M; Palmqvist R; Wahlin BE; Wahlin A
Sci Rep; 2015 Jan; 5():7920. PubMed ID: 25605402
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.
Rodriguez-Otero P; Porcher R; Peffault de Latour R; Contreras M; Bouhnik Y; Xhaard A; Andreoli A; Ribaud P; Kapel N; Janin A; Socié G; Robin M
Blood; 2012 Jun; 119(24):5909-17. PubMed ID: 22555971
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD.
O'Meara A; Kapel N; Xhaard A; Sicre de Fontbrune F; Manéné D; Dhedin N; de Latour RP; Socié G; Robin M
Bone Marrow Transplant; 2015 Aug; 50(8):1105-9. PubMed ID: 25961766
[TBL] [Abstract][Full Text] [Related]
6. Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; De Michele T; Zuppi C; Bacigalupo AP; Sica S; Chiusolo P
Ann Hematol; 2017 Jun; 96(6):929-933. PubMed ID: 28293713
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
[No Abstract] [Full Text] [Related]
8. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.
Legoff J; Resche-Rigon M; Bouquet J; Robin M; Naccache SN; Mercier-Delarue S; Federman S; Samayoa E; Rousseau C; Piron P; Kapel N; Simon F; Socié G; Chiu CY
Nat Med; 2017 Sep; 23(9):1080-1085. PubMed ID: 28759053
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of patients with acute graft-versus-host disease of the upper digestive tract.
Nomura K; Iizuka T; Kaji D; Yamamoto H; Kuribayashi Y; Kimura R; Yamada A; Furuhata T; Yamashita S; Kikuchi D; Matsui A; Mitani T; Ogawa O; Hoteya S; Ota Y; Taniguchi S; Kaise M
J Gastroenterol Hepatol; 2014 Nov; 29(11):1867-72. PubMed ID: 24909520
[TBL] [Abstract][Full Text] [Related]
11. Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation.
Calabrese E; Zorzi F; Visconti E; De Angelis G; Cerretti R; Del Vecchio Blanco G; Picardi A; Cudillo L; Postorino M; Franceschini L; Biancone L; Arcese W; Pallone F
Dig Liver Dis; 2013 Nov; 45(11):899-904. PubMed ID: 23680035
[TBL] [Abstract][Full Text] [Related]
12. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.
Ross WA; Ghosh S; Dekovich AA; Liu S; Ayers GD; Cleary KR; Lee JH; Couriel D
Am J Gastroenterol; 2008 Apr; 103(4):982-9. PubMed ID: 18028511
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
17. Significance of colonoscopy in patients with intestinal graft-versus-host disease after hematopoietic stem cell transplantation.
Oomori S; Takagi S; Kikuchi T; Utsunomiya K; Yokoyama H; Negoro K; Tohmiya Y; Aihara H; Yamada M; Takahashi S; Kameoka J; Kinouchi Y; Shimosegawa T
Endoscopy; 2005 Apr; 37(4):346-50. PubMed ID: 15824945
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
[TBL] [Abstract][Full Text] [Related]
19. Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation.
Chiusolo P; Metafuni E; Giammarco S; Bellesi S; Piccirillo N; Fanali C; Castagnola M; Zuppi C; De Michele T; Leone G; Sica S
Blood; 2012 Nov; 120(22):4443-4. PubMed ID: 23175663
[No Abstract] [Full Text] [Related]
20. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Maziarz RT; Devos T; Bachier CR; Goldstein SC; Leis JF; Devine SM; Meyers G; Gajewski JL; Maertens J; Deans RJ; Van't Hof W; Lazarus HM
Biol Blood Marrow Transplant; 2015 Apr; 21(4):720-8. PubMed ID: 25555450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]